Eiger BioPharmaceuticals ...

NASDAQ: EIGR · Real-Time Price · USD
1.73
0.00 (0.29%)
At close: Apr 03, 2024, 3:59 PM

Eiger BioPharmaceuticals Revenue

Eiger BioPharmaceuticals reported an annual revenue of $15.77M, reflecting a 16.98% growth. For the quarter ending December 31, 2023, Eiger BioPharmaceuticals generated $3.8M in revenue.
Revenue (ttm)
$15.77M
Revenue Growth
16.98%
Price / Sales Ratio
0.63
Revenue / Employee
$281.66K
Employees
56
Market Cap
2.55M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.